Published in Transplant Proc on October 01, 2011
Sarcopenia and liver transplant: The relevance of too little muscle mass. World J Gastroenterol (2015) 0.76
Use of Six-Minute Walk Test to Measure Functional Capacity After Liver Transplantation. Phys Ther (2016) 0.75
Inspiratory Muscle Training and Functional Capacity in Patients Undergoing Cardiac Surgery. Braz J Cardiovasc Surg (2016) 0.75
Functional Capacity, Respiratory Muscle Strength, and Oxygen Consumption Predict Mortality in Patients with Cirrhosis. Can J Gastroenterol Hepatol (2016) 0.75
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Intracranial aneurysms in autosomal dominant polycystic kidney disease. AJNR Am J Neuroradiol (2013) 1.42
Liver transplantation in Eastern Europe. Liver Transpl (2000) 1.39
Review and prospects of magnonic crystals and devices with reprogrammable band structure. J Phys Condens Matter (2014) 1.36
Magnonic band engineering by intrinsic and extrinsic mirror symmetry breaking in antidot spin-wave waveguides. Sci Rep (2013) 1.20
Evidence against the exon theory of genes derived from the triose-phosphate isomerase gene. Proc Natl Acad Sci U S A (1995) 1.06
A human putative Suv3-like RNA helicase is conserved between Rhodobacter and all eukaryotes. Acta Biochim Pol (1999) 1.01
Implications of overweight in gastric cancer: A multicenter study in a Western patient population. Eur J Surg Oncol (2010) 1.00
Diagnosis and treatment of sigmoidal endometriosis--a case report. Med Sci Monit (2001) 0.98
Forbidden band gaps in the spin-wave spectrum of a two-dimensional bicomponent magnonic crystal. Phys Rev Lett (2012) 0.96
Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. Oncology (2010) 0.96
Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int J Exp Pathol (2007) 0.95
14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Tissue Antigens (2007) 0.95
The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome. Vet Pathol (2010) 0.94
Erratic evolution of glycerol-3-phosphate dehydrogenase in Drosophila, Chymomyza, and Ceratitis. J Mol Evol (1997) 0.92
Outcome of four high-risk pregnancies in female liver transplant recipients on tacrolimus immunosuppression. Transplant Proc (2006) 0.89
Treatment of early hepatic artery thrombosis after liver transplantation. Transplant Proc (2011) 0.88
Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma. Aliment Pharmacol Ther (2010) 0.88
Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med (2010) 0.87
Choice of transplantation techniques and indications for liver transplantation in polycystic liver disease in patients with no signs of end-stage liver disease. Transplant Proc (2008) 0.87
Investigations of morphological structure of acupuncture points and meridians. J Tradit Chin Med (1985) 0.86
Posttransplant lymphoproliferative disorder of the lung in a renal transplant recipient treated successfully with surgery. Transplant Proc (2006) 0.85
Correlation between selected prognostic factors and postoperative course in liver transplant recipients. Transplant Proc (2009) 0.84
Orthotopic liver transplantation for cholestatic diseases. Hepatogastroenterology (2010) 0.84
Vascular complications related to liver transplantation. Transplant Proc (2000) 0.84
A threat of the Klebsiella pneumoniae carbapenemase-producing strains among transplant recipients. Transplant Proc (2011) 0.83
Diagnostic value of adenosine deaminase in some liver diseases. Clin Chim Acta (1966) 0.83
Patient with liver epithelioid hemangioendothelioma treated by transplantation: 3 years' observation. Transplant Proc (2006) 0.83
Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report. Transplant Proc (2006) 0.83
Pathomorphological features of acute rejection in patients after orthotopic liver transplantation: own experience. Transplant Proc (2006) 0.83
Recurrence of primary sclerosing cholangitis in patients after liver transplantation. Transplant Proc (2006) 0.83
TIPS: a therapy to prevent variceal rebleeding in patients listed for liver transplantation. Transplant Proc (2002) 0.83
Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters. Transplant Proc (2009) 0.83
Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center. Transplant Proc (2009) 0.82
Biliary tract complications following liver transplantation. Transplant Proc (2003) 0.82
Assessment of early biliary complications after orthotopic liver transplantation and their relationship to the technique of biliary reconstruction. Transplant Proc (2006) 0.81
Results of treatment of acute liver failure patients with use of the prometheus FPSA system. Transplant Proc (2009) 0.81
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis. Clin Transpl (2007) 0.81
The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. Transplant Proc (2006) 0.81
Low-dose hormonal contraception after liver transplantation. Transplant Proc (2007) 0.81
Pregnancy outcomes among female recipients after liver transplantation: further experience. Transplant Proc (2011) 0.80
Dysphagia and retrosternal pain related to a round plastic foreign body impacted in the esophageal wall for over 20 years. Endoscopy (2008) 0.80
Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transplant Proc (2003) 0.80
Liver regeneration in 120 consecutive living-related liver donors. Transplant Proc (2009) 0.80
Biliary complications in relation to the technique of biliary reconstruction in adult liver transplant recipients. Transplant Proc (2007) 0.80
Liver transplantation in patients with hepatic failure. Transplant Proc (2002) 0.79
Vascular complications after liver transplantation. Transplant Proc (2003) 0.79
High-resolution 1H nuclear magnetic resonance spectroscopy analysis of bile samples obtained from a patient after orthotopic liver transplantation: new perspectives. Transplant Proc (2003) 0.79
Resection of the liver in a metastatic disease caused by renal carcinoma. Mater Med Pol (1995) 0.79
Tremor associated with focal and segmental dystonia. Neurol Neurochir Pol (2013) 0.79
Efficacy of antibiotic penetration into pancreatic necrosis. HPB (Oxford) (2006) 0.79
Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun (1998) 0.79
The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST). Neoplasma (2003) 0.78
Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer. Transplant Proc (2013) 0.78
Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice. Life Sci (2000) 0.78
Preoperative concurrent chemotherapy and radiotherapy for local-regional and advanced squamous cell carcinoma of the thoracic oesophagus: preliminary results of a pilot study. Eur J Surg Oncol (1991) 0.78
Orthotopic liver transplantation for fulminant hepatic failure. Transplant Proc (2006) 0.78
Early results of orthotopic liver transplantations using the technique of inferior vena cava anastomosis. Transplant Proc (2006) 0.78
Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action. Curr Med Chem (2001) 0.78
Intestine as source of cytokines and growth factors. Transplant Proc (2009) 0.78
Tremor in neurodegenerative ataxias, Huntington disease and tic disorder. Neurol Neurochir Pol (2013) 0.77
Menstrual function in female liver transplant recipients of reproductive age. Transplant Proc (2009) 0.77
Variability of the renal lymph nodes in Wistar rats. Folia Morphol (Warsz) (1994) 0.77
New concepts in organ transplantation. Transplant Proc (2004) 0.77
Anatomical alteration of the vascular tree observed during living related liver transplantation. Transplant Proc (2003) 0.77
Prediction of graft loss and death in patients with primary sclerosing cholangitis. Transplant Proc (2009) 0.77
Comparison of the results of liver transplantation for elective versus urgent indications. Transplant Proc (2003) 0.77
Current treatments of primary sclerosing cholangitis. Curr Med Chem (2007) 0.77
Is Taurolidine a candidate for treatment of rheumatoid arthritis? Clin Exp Rheumatol (2007) 0.77
Liver retransplantation: indications and results. Transplant Proc (2002) 0.77
Immature hepatic tumor of bimodal differentiation in a young adult patient: a novel lesion expressing beta-catenin and mimicking a distinct phase of hepatogenesis. J Hepatol (2001) 0.77
Cytomegalovirus infection as a common complication following liver transplantation. Transplant Proc (2003) 0.77
Clinical significance of lymphocytes hepatocyte growth factor mRNA expression in patients after liver transplantation. Transplant Proc (2007) 0.77
Influence of selected factors on survival after liver retransplantation. Transplant Proc (2011) 0.77
Proteolytic enzymes activities in patients after myocardial infarction correlate with serum concentration of TGF-beta. Inflammation (2004) 0.77
Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors. Ann Transplant (2007) 0.77
Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma. Transplant Proc (2009) 0.76
The relevance of intestinal dysbiosis in liver transplant candidates. Transpl Infect Dis (2015) 0.76
Results of surgical treatment of cervical esophageal diverticula. Dis Esophagus (1998) 0.76
Comparison of modifications of the rosette test for detecting T lymphocytes. Arch Immunol Ther Exp (Warsz) (1976) 0.76
[Analysis of morbidity risk in patients after liver resection]. Wiad Lek (1997) 0.76
Acute liver transplant rejection: incidence and the role of high-doses steroids. Transplant Proc (2003) 0.76
Transplant glomerulopathy: clinical and pathological correlations. Transplant Proc (2009) 0.76
The dominant sequence types of vancomycin-resistant Enterococcus faecium among transplantation ward patients. Transplant Proc (2011) 0.76
Prevalence and predictors of acute renal injury in liver transplant recipients. Transplant Proc (2009) 0.76
Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection. Vox Sang (2005) 0.76
Liver transplantation: comparison of the classical orthotopic and piggyback techniques. Transplant Proc (2002) 0.76
Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo. Int J Mol Med (1999) 0.76
Hepatic artery reconstruction prior to orthotopic liver transplantation. Transplant Proc (2003) 0.75
Effect of immunosuppressive regimen on acute rejection and liver graft function. Transplant Proc (2003) 0.75
Pregnancy and delivery after liver transplantation. Transplant Proc (2005) 0.75
Gas exchange abnormalities in patients listed for liver transplantation. J Physiol Pharmacol (2006) 0.75